Literature DB >> 729579

The LD-carboxypeptidase activity in Gaffkya homari. The target of the action of D-amino acids or glycine on the formation of wall-bound peptidoglycan.

W P Hammes.   

Abstract

The effects in vitro of D-amino acids or glycine on the formation of wall-bound peptidoglycan were studied with wall membrane enzyme preparations from Gaffkya homari. These amino acids inhibited the incorporation of nascent peptidoglycan into the preformed polymer (e.g. ID50 values for D-alanine, D-leucine, and glycine = 5.6 mmol/l, 1.3 mmol/l, and 11 mmol/l, respectively). The inhibition was accompanied by an incorporation of the inhibitor into position 4 of the peptide subunit Ala1-DGlu2(Lys3-DAla4), where the indices refer to the position of an amino acid residue within the peptide subunit. It is suggested that the reaction is catalyzed by an LD-carboxypeptidase. Therefore, this enzyme has also D-amino acid exchange activity. At inhibitory concentration fewer tripeptide subunits were formed in the nascent peptidoglycan in favour of the formation of tetrapeptide subunits bearing the inhibitor at the C termini. The tripeptide subunits are assumed to be necessary in order that nascent peptidoglycan is utilized as substrate in the transpeptidation reaction. Thus an essential role of the LD-carboxypeptidase is indicated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729579     DOI: 10.1111/j.1432-1033.1978.tb12703.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

Review 1.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

2.  Protection by D-amino acids against growth inhibition and lysis caused by beta-lactam antibiotics.

Authors:  E Tuomanen; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

3.  Effect of glycine on Helicobacter pylori in vitro.

Authors:  Masaaki Minami; Takafumi Ando; Shin-Nosuke Hashikawa; Keizo Torii; Tadao Hasegawa; Dawn A Israel; Kenji Ina; Kazuo Kusugami; Hidemi Goto; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  LD-carboxypeptidase activity in Escherichia coli. I. The LD-carboxypeptidase activity in ether treated cells.

Authors:  R Metz; S Henning; W P Hammes
Journal:  Arch Microbiol       Date:  1986-03       Impact factor: 2.552

5.  LD-carboxypeptidase activity in Escherichia coli. II. Isolation, purification and characterization of the enzyme from E. coli K 12.

Authors:  R Metz; S Henning; W P Hammes
Journal:  Arch Microbiol       Date:  1986-03       Impact factor: 2.552

6.  Biosynthesis of peptidoglycan in Gaffkya homari: reactivation of membranes by freeze-thawing in the presence and absence of walls.

Authors:  E Kalomiris; C Bardin; F C Neuhaus
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

7.  Membrane-wall interrelationship in Gaffkya homari: sulfhydryl sensitivity and heat lability of nascent peptidoglycan incorporation into walls.

Authors:  F C Neuhaus; C E Tobin; J A Ahlgren
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

8.  Biosynthesis of peptidoglycan in Gaffkya homari: processing of nascent glycan by reactivated membranes.

Authors:  C Bardin; R K Sinha; E Kalomiris; F C Neuhaus
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

9.  In vivo target of benzylpenicillin in Gaffkya homari.

Authors:  P W Wrezel; L F Ellis; F C Neuhaus
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

10.  Characterization of the peptidoglycan of vancomycin-susceptible Enterococcus faecium.

Authors:  Gary J Patti; Sung Joon Kim; Jacob Schaefer
Journal:  Biochemistry       Date:  2008-07-19       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.